Boston - Researchers reported yesterday they may have found a way to prevent lasting liver damage in virtually every case of hepatitis C if treatment begins during the earliest stages of the potentially fatal infection.
The report, which could affect the treatment of hundreds of millions of people infected with the virus, will appear in the November 15th issue of the New England Journal of Medicine. But the editors released the findings early because of the clinical implications.